Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ASTELLAS PHARMA INC
12/08 ASTELLAS PHARMA : Research & Development Meeting Highlights
12/02 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
12/01 ASTELLAS PHARMA : Immunomic Therapeutics Announces Expansion of IP Portfolio
11/30 ASTELLAS PHARMA : Initiatives to Pursue Operational Excellence
11/23 CASE STUDY : Application of SORS (RapID) to In-Container Testing of Raw Material..
11/21 ASTELLAS PHARMA : Antihypertensive Drug 'Micatrio Combination Tablets'
11/18 ASTELLAS PHARMA : Antihypertensive Drug "Micatrio® Combination Tablets"
11/17 ASTELLAS PHARMA : GUINNESS WORLD RECORDS Title Achieved for Organ Donor Registra..
11/09 ASTELLAS PHARMA : GUINNESS WORLD RECORDSTM Title Achieved for Organ Donor Regist..
11/03 ASTELLAS PHARMA : FDA Approves Supplemental New Drug Application for XTANDI enza..
11/03 ASTELLAS PHARMA : to Acquire Ganymed Pharmaceuticals
11/01 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 187KB)
10/31 ASTELLAS PHARMA : Announces Acquisition of Own Shares
10/29 ASTELLAS PHARMA : to acquire German pharmaceutical company
10/29 ASTELLAS PHARMA : to acquire German pharmaceutical company
10/28 ASTELLAS PHARMA : Reports First Half FY2016 Financial Results, Revises Fiscal Ye..
10/28 ASTELLAS PHARMA : to Acquire Ganymed Pharmaceuticals -Acquisition Would Expand '..
10/28 ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 175KB)
10/28 ASTELLAS PHARMA : Reports First Half FY2016 Financial Results, Revises Fiscal Ye..
10/27 ASTELLAS PHARMA : Findings in Kidney Function Reported from Astellas Pharma, Inc..
10/24 ASTELLAS PHARMA : FDA Approves Supplemental New Drug Application for XTANDI (enz..
10/24 ASTELLAS PHARMA : FDA Approves Supplemental New Drug Application for XTANDI in A..
10/21 ASTELLAS PHARMA : Launches Global Campaign in Collaboration with CNN as Part of ..
10/21 ASTELLAS PHARMA : Launches Global Campaign in Collaboration with CNN as Part of ..
10/20 ASTELLAS PHARMA : World Anti-Doping Agency and Astellas Announce Global Initiati..
10/20 ASTELLAS PHARMA : Termination of Business Transfer Discussion with Kaketsuken
10/17 INSPYR THERAPEUTICS, INC. (OTCQB : NSPX) Files An 8-K
10/17 ASTELLAS PHARMA : World Anti-Doping Agency and Astellas Announce Global Initiati..
10/14 ASTELLAS PHARMA : World Anti-Doping Agency and Astellas Announce Global Initiati..
10/13 ASTELLAS PHARMA : Investigators from Astellas Pharma, Inc. Release New Data on M..
10/13 STUDIES CONDUCTED AT ASTELLAS PHARMA : Potential of urinary nephrin as a biomark..
10/13 ASTELLAS PHARMA : Johns Hopkins licensing revenue spikes in fiscal 2016
10/13 ASTELLAS PHARMA : Chromocell and Astellas Announce FDA Fast Track Designation an..
10/12 SEATTLE GENETICS : and Agensys, an Affiliate of Astellas, Highlight Enfortumab V..
10/10 ASTELLAS PHARMA : Filed Lawsuit against Patent Infringement of Myrbetriq in the ..
10/07 ASTELLAS PHARMA : Filed Lawsuit against Patent Infringement of Myrbetriq® in the..
10/06 ASTELLAS PHARMA : Donates 6 Wheelchair Vans through the Flying Star Fund, an Emp..
09/29 ASTELLAS PHARMA : Maruho and Astellas Enter License Agreement for the Developmen..
09/29 ASTELLAS PHARMA : Approval for Manufacturing and Marketing of 'Micatrio Combinat..
09/28 ASTELLAS PHARMA : Receives Approval for Kiklin® Granules, a Treatment for Hyperp..
09/28 ASTELLAS PHARMA : Approval for Manufacturing and Marketing of "Micatrio® Combina..
09/28 ASTELLAS PHARMA INC : ex-dividend day for interim dividend
09/27 VICAL INCORPORATED : and Astellas Announce Topline Results from a Phase 2 Study ..
09/22 Hang Lung Properties to Bring in Conrad Hotel Project
09/16 ASTELLAS PHARMA : Selected as a Dow Jones Sustainability Asia Pacific Index Comp..
09/15 ASTELLAS PHARMA : and MPM debut DigiTx Partners, a digital health investment com..
09/09 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. in the Area of Nuclear Mag..
09/09 ASTELLAS PHARMA : Study Results from Astellas Pharma, Inc. Provide New Insights ..
09/08 ASTELLAS PHARMA : donates ambulances on First Aid Day (September 9)
08/25 ASTELLAS PHARMA : and World Transplant Games Federation Announce Launch of Fit f..
08/24 ASTELLAS PHARMA : Announces Personnel Changes
08/23 ASTELLAS PHARMA : Announces Personnel Changes (pdf 47KB)
08/22 ASTELLAS PHARMA : and World Transplant Games Federation Announce Launch of Fit f..
08/16 ASTELLAS PHARMA : Farma Brasil Ranked Among 20 Greatest Workplaces in Brazil
08/11 ASTELLAS PHARMA : Announces Transfer of U.S. Manufacturing Subsidiary to Avara
08/11 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. in Gamma-aminobutyric Acid..
08/09 PROTEOSTASIS THERAPEUTICS : Achieves Preclinical Milestone in Astellas Pharma Co..
08/05 ASTELLAS PHARMA : Transfers Manufacturing Subsidiary to Avara
08/05 ASTELLAS PHARMA : transfers US manufacturing subsidiary to Avara Norman Pharma
08/04 ASTELLAS PHARMA : Launches DigiTx Partners, a Digital Health Investment Company ..
08/04 ASTELLAS PHARMA : Announces Transfer of U.S. Manufacturing Subsidiary to Avara (..
08/01 ASTELLAS PHARMA : Launches DigiTx Partners, a Digital Health Investment Company ..
07/29 ASTELLAS PHARMA : Launches DigiTx Partners, a Digital Health Investment Company ..
07/29 ASTELLAS PHARMA : Q1 Core Profit Rises; Backs FY Outlook
07/29 ASTELLAS PHARMA : Reports First Quarter Financial Results of FY2016 (pdf 164KB)
07/29 ASTELLAS PHARMA : Reports First Quarter Financial Results of FY2016
07/26 ASTELLAS PHARMA : and FibroGen Announce First Patient Treated in Phase 3 Studies..
07/14 ASTELLAS PHARMA : "Pharmaceutical Composition for Modified Use" in Patent Applic..
07/09DJCorrections & Amplifications -- WSJ
07/07 ASTELLAS PHARMA : Recent Findings from Astellas Pharma, Inc. Has Provided New Da..
07/06 ASTELLAS PHARMA : Named to FTSE4Good Sustainability Index for the Fifth Consecut..
06/28 ASTELLAS PHARMA : Farma Brasil Among Top 3 Workplaces in Brazilian Pharmaceutica..
06/23 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Provides New Data about Th..
06/23 ASTELLAS PHARMA : The Institute of Medical Science, the University of Tokyo and ..
06/20 ASTELLAS PHARMA : NIH won't cut price of taxpayer-funded prostate cancer drug
1  2  3  4  5  6Next
Advertisement
Financials ( JPY)
Sales 2017 1 320 118 M
EBIT 2017 275 000 M
Net income 2017 202 215 M
Finance 2017 478 969 M
Yield 2017 2,26%
P/E ratio 2017 15,95
P/E ratio 2018 15,11
EV / Sales 2017 2,14x
EV / Sales 2018 1,96x
Capitalization 3 300 734 M
More Financials
Chart ASTELLAS PHARMA INC
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Full-screen chart
Technical analysis trends ASTELLAS PHARMA INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 1 952  JPY
Spread / Average Target 27%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Yoshihiko Hatanaka President, CEO & Representative Director
Masafumi Nogimori Chairman
Yasumasa Masuda Senior Executive Officer & Head-Finance
Mitsunori Matsuda Senior Executive Officer & GM-Technology
Yoshiro Miyokawa Representative Director & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC-10.80%28 621
JOHNSON & JOHNSON9.29%305 407
ROCHE HOLDING LTD.-17.58%193 824
PFIZER INC.-4.15%192 367
NOVARTIS AG-18.49%182 959
MERCK & CO., INC.15.92%168 820
More Results